HHS Secretary Becerra has ordered Medicare to reassess the spike in Part B premiums now that Biogen has cut the price of Alzheimer’s drug Aduhelm from $56,000 to $28,200 a year.
https://news.yahoo.com/medicare-told-reassess-premium-hike-1…
intercst
4 Likes
Aduhelm should never have been approved. Medicare should refuse to cover it.
Wendy
3 Likes